The present invention provides a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagencity. Provided is a compound represented by the following formula (1) or a salt thereof:
wherein A
1
, A
2
, A
3
and A
4
independently represents a carbon or nitrogen; R
1
is a halogen substituent; R
2
is a halogen substituent; and m is an integer of 0 to 2, provided that at least one of R
1
and R
2
is a radioactive halogen substituent, at least one of A
1
, A
2
, A
3
and A
4
represents a carbon, and R
1
binds to a carbon represented by A
1
, A
2
, A
3
or A
4
as well as a low-toxic diagnostic agent comprising a compound represented by the preceding formula or a salt thereof.
The present invention provides a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagencity. Provided is a compound represented by the following formula (1) or a salt thereof:
wherein A
1
, A
2
, A
3
and A
4
independently represents a carbon or nitrogen; R
1
is a halogen substituent; R
2
is a halogen substituent; and m is an integer of 0 to 2, provided that at least one of R
1
and R
2
is a radioactive halogen substituent, at least one of A
1
, A
2
, A
3
and A
4
represents a carbon, and R
1
binds to a carbon represented by A
1
, A
2
, A
3
or A
4
as well as a low-toxic diagnostic agent comprising a compound represented by the preceding formula or a salt thereof.
Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid
申请人:Nihon Medi-Physics Co., Ltd.
公开号:US08303935B2
公开(公告)日:2012-11-06
The present invention provides a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagencity. Provided is a compound represented by the following formula (1) or a salt thereof:
wherein A1, A2, A3 and A4 independently represents a carbon or nitrogen; R1 is a halogen substituent; R2 is a halogen substituent; and m is an integer of 0 to 2, provided that at least one of R1 and R2 is a radioactive halogen substituent, at least one of A1, A2, A3 and A4 represents a carbon, and R1 binds to a carbon represented by A1, A2, A3 or A4 as well as a low-toxic diagnostic agent comprising a compound represented by the preceding formula or a salt thereof.
The invention relates to a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagenicity, and also relates to a low-toxic diagnostic agent for Alzheimer's disease containing the compound. The compound is represented by the following formula (1) or a salt thereof:
wherein A
1
, A
2
, A
3
and A
4
independently represent a carbon or a nitrogen, and
R
3
is a group represented by the following formula:
wherein R
1
is a radioactive halogen substituent; m is an integer of 0 to 4; and n is an integer of 0 or 1, provided that at least one of A
1
, A
2
, A
3
and A
4
represents a carbon, and R
3
binds to a carbon represented by A
1
, A
2
, A
3
or A
4
.
The invention relates to a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagenicity, and also relates to a low-toxic diagnostic agent for Alzheimer's disease containing the compound. The compound is represented by the following formula (1) or a salt thereof:
wherein A1, A2, A3 and A4 independently represent a carbon or a nitrogen, and
R3 is a group represented by the following formula:
wherein R1 is a radioactive halogen substituent; m is an integer of 0 to 4; and n is an integer of 0 or 1, provided that at least one of A1, A2, A3 and A4 represents a carbon, and R3 binds to a carbon represented by A1, A2, A3 or A4.